genekam logo
  • usa
    • german
    • russia
    • china
Duissernstr. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555858-31,-32,-33 · Fax: +49 203 / 35 82 99
menuicon
slider
Latest News:

08.08.2018
Genekam is working on potential therapeutic molecules and antibodies against pandemic influenza viruses

Latest News:

13.06.2018
3D Genomemedicine Inc is going to operate in USA

  • BIO 2019

    Visit us at BIO 2019 in Philadelphia, USA:
    03.06. - 06.06 2019

  • MEDICA 2019

    Visit us at MEDICA in Duesseldorf, Germany:
    18.11.19 - 21.11.19

  • BIO 2019

    Visit us at BIO 2019 in Philadelphia, USA:
    03.06. - 06.06 2019

  • MEDICA 2019

    Visit us at MEDICA in Duesseldorf, Germany:
    18.11.19 - 21.11.19

T-cell immunotherapy solution - car T-cell therapy

There are many laboratories developing CAR T-cell therapies. Genekam has a number of kits to develop CAR T-Cell therapy e.g. isolate large number of T cells (CD4 / CD8) from blood or other source. This isolation kit will generate larger number of needed T cells against number of cells generated through density gradient methods (also called Ficolle), Magnetic beads based Kits are for separation of wanted T cells from other unwanted cells. After that they can be stimulated or undergo the cloning with specific vectors carrying specific sequences. Genekam has developed a kit, which can remove the unwanted erythrocytes, which may be disturbing factors during the development. This can accelerate the development of CAR T-cells therapies against any possible target in field oncology, virology or transplantation medicine. These kits help to make therapies economically.
TOP